Luramax 80mg Tablet contains Lurasidone, an atypical antipsychotic indicated for the treatment of schizophrenia and bipolar depression. Lurasidone exerts its therapeutic effects primarily through antagonism of dopamine D2 and serotonin 5-HT2A receptors, contributing to the modulation of neurotransmitter activity implicated in psychotic and mood disorders. This medication is prescribed to alleviate symptoms such as hallucinations, delusions, mood swings, and depressive episodes associated with these conditions. Luramax 80mg is administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects may include nausea, somnolence, akathisia, and extrapyramidal symptoms; thus, patients should be monitored regularly. It is contraindicated in individuals with known hypersensitivity to Lurasidone or any tablet components. Caution is advised when used in patients with a history of seizures, cardiovascular disease, or metabolic abnormalities. Luramax should be used under strict medical supervision, with periodic assessment of therapeutic efficacy and side effects. Patients are advised to avoid alcohol and inform their healthcare provider of all concomitant medications to prevent potential drug interactions. This medication should not be abruptly discontinued to avoid withdrawal symptoms or relapse. Luramax 80mg Tablet offers an effective option for managing complex psychiatric disorders when integrated into a comprehensive treatment plan.